| Trial registration number
|
NCT04641195 |
Full text link
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04641195
|
First author
Last imported at : Sept. 21, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
None
|
Contact
Last imported at : Sept. 21, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
None
|
Registration date
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2020-11-23
|
Recruitment status
Last imported at : Sept. 21, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Factorial
|
Masking
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 11, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
aged >=18 years old
polymerase chain reaction (pcr) or rapid antigen test (rat)-confirmed infection with sars-cov2
provide informed consent
|
Exclusion criteria
Last imported at : Feb. 11, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
pregnancy
enrollment in other clinical trials
|
Number of arms
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
4
|
Funding
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Harvard School of Public Health (HSPH)
|
Inclusion age min
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
India
|
Type of patients
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Sept. 21, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
181
|
primary outcome
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Time to recovery
|
Notes
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : Nov. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1371, "treatment_name": "Vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1397, "treatment_name": "Zinc", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2269, "treatment_name": "Vitamin d3+zinc", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|